Announcing the launch of the SmartTRAK Computer Assisted Surgery - Spine with a focus on surgical robotics.
SmartTRAK’s Computer Assisted Surgery - Spine covers:
The module provides real time, up-to-date market data, including 5-year market and procedural projections, quarterly revenue tracking, competitive overviews, clinical and regulatory activities and much more.
Foreign currency exchange rates boosted reported WW market growth, while the US market failed to rebound as expected
In Q218, positive foreign currency exchange rates boosted reported growth again in the WW Total Joints Market, while the US market grew sequentially but with a less-than-expected rebound following challenges in Q118...Among the many topics covered in detail in the Q218 Total Joints Market Recap are:
Stability in the US and in International Growth
While the Spine market remains sluggish in the US, international sales are picking up the slack. The Q2 WW Spine Hardware market improved nearly 2% during the quarter despite...
Among the many topics covered in the Q218 Spine Market Recap are:
Computer Assisted Surgery - Spine is the latest module added to SmartTRAK Business Intelligence and Will Be Launched at the North American Spine Surgery (NASS) Meeting
BioMedGPS announces expanded coverage of SmartTRAK Business Intelligence in the realm of Robotic and Computer Assisted Surgery with the launch of its first module, US Computer Assisted Surgery (CAS) – Spine at the upcoming NASS conference later this month. A second SmartTRAK module, US Computer Assisted Surgery (CAS) – Ortho, will be introduced in November.
Extremities market experiences slight gains due to expanded product portfolios
The US Extremities Market experienced a slight gain in Q218 according to SmartTRAK Financial Dashboard, slightly lower than the rate anticipated in the US Extremities Market Overview. We anticipate the Extremities segment rebounding to achieve...Among the many topics covered in the Q218 Extremities Market Recap are:
US market experiences slight softening as the top four trauma players all post sequential declines in Q218
The WW Trauma Market was up in Q218 – the third consecutive quarter of growth in the +4% range. Internationally, positive sales growth in Europe offset a sequential slowdown in Rest of World (ROW). In Europe, revenues were steady, while ROW sales dipped sequentially as the top players reported softer growth due to tough comps as a result of 2017 tender orders...Among the many topics covered Q218 Trauma Market Recap are:
Volume Up, Pricing Down, Overall Market Lower
Now that Q218 results are in, the US Joint Fluid market continued to experience downward pressure posting negative growth of -6.5% for the quarter and -4.0% YTD, according to SmartTRAK Financial Dashboard results ...
Cerapedics’ CEO Glen Kashuba and President and COO Jeff Marx, Ph.D. discuss the future of the bone graft substitutes and the uniqueness of i‑FACTOR Peptide Enhanced Bone Graft, a small peptide technology in an interview with Kim French, Sr. Analyst, SmartTRAK Orthbio.
A transcript of SmartTRAK's interview with Glen Kashuba and Jeff Marx is below, or click on the following video to listen to the interview.
SmartTRAK is excited to be attending AOFAS 2018 - American Orthopaedic Foot & Ankle Society - on July 11-14, 2018 in Boston, Massachusetts.
Representing SmartTRAK will be Natasha Weeks, Sr. Analyst, Trauma & Extremities Fixation, Christopher McCarthy, VP Corporate Accounts, Orthopedics and Neuro and Michelle Calderon, Account Manager, Orthopedics. Please contact us if you would like a meeting!
SmartTRAK looks behind the curtain at the interplay of factors truly driving growth in the US Soft Tissue Fixation Market.
With the US Soft Tissue Fixation Market worth an estimated $1.5B, SmartTRAK looked behind industry’s curtain at the interplay of factors driving the 5.3% CAGR in the sports medicine market to see what’s truly driving growth in the market. Does clinical research drive product development? Or does industry develop and market products that drive usage followed by studies that measure their efficacy? From aggressive marketing campaigns to company compensation plans to sole source agreements, there is an increasing number of factors driving the soft tissue fixation market outside of research and clinical findings.
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services.